-
Product Insights
NewLikelihood of Approval Analysis for Chemotherapy Induced Neutropenia
Overview How likely is it that the drugs in Chemotherapy Induced Neutropenia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chemotherapy Induced Neutropenia Overview Chemotherapy-induced neutropenia is a very common side...
-
Product Insights
NewLikelihood of Approval Analysis for Chemotherapy Induced Nausea and Vomiting
Overview How likely is it that the drugs in Chemotherapy Induced Nausea and Vomiting will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chemotherapy Induced Nausea and Vomiting Overview Chemotherapy-induced nausea and...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Mesdopetam in Drug-Induced Dyskinesia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mesdopetam in Drug-Induced Dyskinesia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mesdopetam in Drug-Induced Dyskinesia Drug Details: Mesdopetam (IRL-790) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Desidustat in Chemotherapy Induced Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Desidustat in Chemotherapy Induced Anemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Desidustat in Chemotherapy Induced Anemia Drug Details: Desidustat (Oxemia) is an erythropoietin-stimulating...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VLX-1005 in Heparin-Induced Thrombocytopenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VLX-1005 in Heparin-Induced Thrombocytopenia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VLX-1005 in Heparin-Induced Thrombocytopenia Drug Details: VLX-1005 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ibudilast in Chemotherapy Induced Peripheral Neuropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ibudilast in Chemotherapy Induced Peripheral Neuropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ibudilast in Chemotherapy Induced Peripheral Neuropathy Drug Details: Ibudilast (Ketas)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Melatonin in Chemotherapy Induced Oral Mucositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Melatonin in Chemotherapy Induced Oral Mucositis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Melatonin in Chemotherapy Induced Oral Mucositis Drug Details: Melatonin (SP-13004)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Olanzapine in Chemotherapy Induced Nausea and Vomiting
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Olanzapine in Chemotherapy Induced Nausea and Vomiting report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Olanzapine in Chemotherapy Induced Nausea and Vomiting Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ferric Carboxymaltose in Chemotherapy Induced Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ferric Carboxymaltose in Chemotherapy Induced Anemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ferric Carboxymaltose in Chemotherapy Induced Anemia Drug Details: Ferric carboxymaltose...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy Drug Details: Tetrodotoxin (TTX,...